News

In pre-clinical asthma models ASM-024 exhibited the capabilities of inhibitory effects on inflammation, bronchoprotection and smooth muscle relaxation. Asmacure founder and chief medical officer Yvon Cormier said the

The site, which is part of the Group’s Specialist Packaging Division, has invested in the Prati Vega booklet-label machine to further improve its quality performance across several study

The BCID panel provides automatic results for the most common infectious causes of sepsis and simultaneously tests positive blood cultures for approximately 90% of the gram-positive bacteria, gram-negative

Mochida Pharmaceutical obtained drug marketing approval for Epadel T, indicated for triglyceride levels that are in the borderline region. The ethical drugs Epadel were converted into an OTC

The primary efficacy endpoints of both the AWARD-2 and AWARD-4 studies were non-inferiority to insulin glargine, as measured by the reduction of hemoglobin A1c (HbA1c) levels at the

As per the joint venture agreement, both the companies will equally share in decision making regarding product development and commercialization where in Agila Biotech will be a 51%

The funds will support Immunovaccine’s RSV program advancement, including formulation of RSV antigens in DepoVax vaccine adjuvanting technology. Immunovaccine chief executive officer John Trizzino said at present there

The payment technology platforms will ensure that clinical trial payments from sponsor to site and from site to subjects are compliant with relevant regulations, including the Sunshine Act.

In 2009, the American Civil Liberties Union and the Public Patent Foundation filed a suit against Myriad Genetics that has patents for BRCA1 and BRCA2 genes, mutations coupled